Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Indivior
Marketing
Indivior-backed paper spotlights rapid opioid reversal meds
Indivior shared the publication on Fentanyl Awareness Day, touting its Opvee as an overdose reversal med that aligns with the paper’s recommendations.
Andrea Park
Apr 29, 2025 9:30am
Top investor Oaktree calls for board shake-up at Indivior
Nov 8, 2024 10:50am
Indivior on the hook for $86M in multi-state opioid settlement
Jul 29, 2024 11:22am
Indivior grounds schizophrenia drug, triggering 130 layoffs
Jul 10, 2024 11:39am
Indivior to fork over $385M in Suboxone antitrust settlement
Oct 23, 2023 1:37pm
Indivior's overdose rescue spray Opvee crosses FDA finish line
May 23, 2023 2:42pm
